Lam Research (LRCX) Tops Q4 EPS by 73c; Guides Above Views

Lam Research (NASDAQ: LRCX) reported Q4 EPS of $4.78, $0.73 better than the analyst estimate of $4.05. Revenue for the quarter came in at $2.79 billion versus the consensus estimate of $2.68 billion.

“Lam delivered strong financial results in the June quarter despite tremendous global health, macroeconomic, and geopolitical uncertainty,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “This is a clear demonstration of our Company’s ability to adapt and execute in a period of unprecedented challenges. With an outlook for continued industry growth, we are in an excellent position to outperform as our investments in disruptive innovation and differentiated customer support gain momentum.”

GUIDANCE:

Lam Research sees Q1 2021 EPS of $4.75-$5.55, versus the consensus of $4.14. Lam Research sees Q1 2021 revenue of $2.9-3.3 billion, versus the consensus of $2.72 billion.

For earnings history and earnings-related data on Lam Research (LRCX) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• European stocks rise, helped by positive global sentiment; NatWest gains
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance